EP2891089A2 - Safeguarding techniques for a closed-loop insulin infusion system - Google Patents

Safeguarding techniques for a closed-loop insulin infusion system

Info

Publication number
EP2891089A2
EP2891089A2 EP13753741.1A EP13753741A EP2891089A2 EP 2891089 A2 EP2891089 A2 EP 2891089A2 EP 13753741 A EP13753741 A EP 13753741A EP 2891089 A2 EP2891089 A2 EP 2891089A2
Authority
EP
European Patent Office
Prior art keywords
insulin
sensor
closed
value
glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP13753741.1A
Other languages
German (de)
English (en)
French (fr)
Inventor
John J. Mastrototaro
Benyamin Grosman
Neha J. Parikh
Anirban Roy
Desmond Barry Keenan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Minimed Inc
Original Assignee
Medtronic Minimed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/870,902 external-priority patent/US9364609B2/en
Priority claimed from US13/966,114 external-priority patent/US9662445B2/en
Priority claimed from US13/966,120 external-priority patent/US9849239B2/en
Priority claimed from US13/966,101 external-priority patent/US9878096B2/en
Priority claimed from US13/966,109 external-priority patent/US9623179B2/en
Application filed by Medtronic Minimed Inc filed Critical Medtronic Minimed Inc
Priority to EP15157703.8A priority Critical patent/EP2897071B1/en
Priority to EP15157701.2A priority patent/EP2897070A1/en
Publication of EP2891089A2 publication Critical patent/EP2891089A2/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1495—Calibrating or testing of in-vivo probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14248—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M2005/14208—Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Biophysics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Optics & Photonics (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • External Artificial Organs (AREA)
EP13753741.1A 2012-08-30 2013-08-14 Safeguarding techniques for a closed-loop insulin infusion system Withdrawn EP2891089A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP15157703.8A EP2897071B1 (en) 2012-08-30 2013-08-14 Safeguarding techniques for a closed-loop insulin infusion system
EP15157701.2A EP2897070A1 (en) 2012-08-30 2013-08-14 Safeguarding techniques for a closed-loop insulin infusion system

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201261694950P 2012-08-30 2012-08-30
US201261694961P 2012-08-30 2012-08-30
US201361812874P 2013-04-17 2013-04-17
US13/870,902 US9364609B2 (en) 2012-08-30 2013-04-25 Insulin on board compensation for a closed-loop insulin infusion system
US13/870,907 US20140066884A1 (en) 2012-08-30 2013-04-25 Sensor model supervisor for a closed-loop insulin infusion system
US13/870,910 US9526834B2 (en) 2012-08-30 2013-04-25 Safeguarding measures for a closed-loop insulin infusion system
US13/966,114 US9662445B2 (en) 2012-08-30 2013-08-13 Regulating entry into a closed-loop operating mode of an insulin infusion system
US13/966,120 US9849239B2 (en) 2012-08-30 2013-08-13 Generation and application of an insulin limit for a closed-loop operating mode of an insulin infusion system
US13/966,101 US9878096B2 (en) 2012-08-30 2013-08-13 Generation of target glucose values for a closed-loop operating mode of an insulin infusion system
US13/966,109 US9623179B2 (en) 2012-08-30 2013-08-13 Safeguarding techniques for a closed-loop insulin infusion system
PCT/US2013/054996 WO2014035672A2 (en) 2012-08-30 2013-08-14 Safeguarding techniques for a closed-loop insulin infusion system

Related Child Applications (4)

Application Number Title Priority Date Filing Date
EP15157701.2A Division EP2897070A1 (en) 2012-08-30 2013-08-14 Safeguarding techniques for a closed-loop insulin infusion system
EP15157701.2A Division-Into EP2897070A1 (en) 2012-08-30 2013-08-14 Safeguarding techniques for a closed-loop insulin infusion system
EP15157703.8A Division EP2897071B1 (en) 2012-08-30 2013-08-14 Safeguarding techniques for a closed-loop insulin infusion system
EP15157703.8A Division-Into EP2897071B1 (en) 2012-08-30 2013-08-14 Safeguarding techniques for a closed-loop insulin infusion system

Publications (1)

Publication Number Publication Date
EP2891089A2 true EP2891089A2 (en) 2015-07-08

Family

ID=52578050

Family Applications (3)

Application Number Title Priority Date Filing Date
EP13753741.1A Withdrawn EP2891089A2 (en) 2012-08-30 2013-08-14 Safeguarding techniques for a closed-loop insulin infusion system
EP15157701.2A Withdrawn EP2897070A1 (en) 2012-08-30 2013-08-14 Safeguarding techniques for a closed-loop insulin infusion system
EP15157703.8A Active EP2897071B1 (en) 2012-08-30 2013-08-14 Safeguarding techniques for a closed-loop insulin infusion system

Family Applications After (2)

Application Number Title Priority Date Filing Date
EP15157701.2A Withdrawn EP2897070A1 (en) 2012-08-30 2013-08-14 Safeguarding techniques for a closed-loop insulin infusion system
EP15157703.8A Active EP2897071B1 (en) 2012-08-30 2013-08-14 Safeguarding techniques for a closed-loop insulin infusion system

Country Status (7)

Country Link
EP (3) EP2891089A2 (zh)
JP (3) JP6073478B2 (zh)
KR (3) KR102054540B1 (zh)
CN (3) CN105046042B (zh)
AU (1) AU2013309344B2 (zh)
CA (3) CA2885003C (zh)
WO (1) WO2014035672A2 (zh)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7959598B2 (en) 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
WO2013016573A1 (en) 2011-07-26 2013-01-31 Glysens Incorporated Tissue implantable sensor with hermetically sealed housing
US10660550B2 (en) 2015-12-29 2020-05-26 Glysens Incorporated Implantable sensor apparatus and methods
US10561353B2 (en) 2016-06-01 2020-02-18 Glysens Incorporated Biocompatible implantable sensor apparatus and methods
US10130767B2 (en) 2012-08-30 2018-11-20 Medtronic Minimed, Inc. Sensor model supervisor for a closed-loop insulin infusion system
GB2523989B (en) 2014-01-30 2020-07-29 Insulet Netherlands B V Therapeutic product delivery system and method of pairing
US10503876B2 (en) 2014-03-12 2019-12-10 Ascensia Diabetes Care Holdings Ag Methods and apparatus for enhancing a medication delivery device
CN105688308A (zh) * 2014-11-13 2016-06-22 上海泽生科技开发有限公司 注射泵控制方法、控制单元及注射泵
US9943645B2 (en) * 2014-12-04 2018-04-17 Medtronic Minimed, Inc. Methods for operating mode transitions and related infusion devices and systems
US9636453B2 (en) 2014-12-04 2017-05-02 Medtronic Minimed, Inc. Advance diagnosis of infusion device operating mode viability
JP2018505756A (ja) 2015-02-18 2018-03-01 インシュレット コーポレイション 流体送達及び注入装置並びにその使用方法
CA3001448A1 (en) * 2015-10-09 2017-04-13 Dianovator Ab Medical arrangements and a method for determining parameters related to insulin therapy, predicting glucose values and for providing insulin dosing recommendations
US10349872B2 (en) * 2015-12-28 2019-07-16 Medtronic Minimed, Inc. Methods, systems, and devices for sensor fusion
US10275573B2 (en) 2016-01-13 2019-04-30 Bigfoot Biomedical, Inc. User interface for diabetes management system
EP3374004B1 (en) 2016-01-14 2023-06-28 Bigfoot Biomedical, Inc. Adjusting insulin delivery rates
US20170332952A1 (en) * 2016-05-23 2017-11-23 Bigfoot Biomedical, Inc. Insulin delivery system and methods with risk based set points
US10638962B2 (en) 2016-06-29 2020-05-05 Glysens Incorporated Bio-adaptable implantable sensor apparatus and methods
EP3984451A1 (en) 2016-06-29 2022-04-20 Roche Diabetes Care GmbH Method for providing a signal quality degree associated with an analyte value measured in a continuous monitoring system
JP6780035B2 (ja) * 2016-06-30 2020-11-04 ノボ・ノルデイスク・エー／エス グルコース測定値およびインスリンペンデータに基づくインスリン治療のための計画アドヒアランス測定
US11462313B2 (en) 2016-08-17 2022-10-04 Novo Nordisk A/S Systems and methods for adjusting a basal/bolus ratio in an insulin regimen
FR3056095B1 (fr) * 2016-09-21 2018-10-12 Commissariat A L'energie Atomique Et Aux Energies Alternatives Systeme automatise de regulation de la glycemie d'un patient
FR3056094B1 (fr) * 2016-09-21 2018-10-12 Commissariat A L'energie Atomique Et Aux Energies Alternatives Systeme automatise de regulation de la glycemie d'un patient
US10765807B2 (en) 2016-09-23 2020-09-08 Insulet Corporation Fluid delivery device with sensor
US10561788B2 (en) * 2016-10-06 2020-02-18 Medtronic Minimed, Inc. Infusion systems and methods for automated exercise mitigation
CA3041938A1 (en) 2016-10-28 2018-05-03 Ascensia Diabetes Care Holdings Ag Methods and apparatus for improved medication delivery devices
US10272201B2 (en) 2016-12-22 2019-04-30 Medtronic Minimed, Inc. Insertion site monitoring methods and related infusion devices and systems
EP3559838A1 (en) * 2016-12-23 2019-10-30 Sanofi-Aventis Deutschland GmbH Data management unit for supporting health control
US10583250B2 (en) 2017-01-13 2020-03-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10610644B2 (en) 2017-01-13 2020-04-07 Bigfoot Biomedical, Inc. Insulin delivery methods, systems and devices
EP3568859A1 (en) 2017-01-13 2019-11-20 Bigfoot Biomedical, Inc. Insulin delivery methods, systems and devices
US10500334B2 (en) 2017-01-13 2019-12-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
WO2018147483A1 (ko) * 2017-02-09 2018-08-16 최규동 연속 혈당 감지를 이용한 인슐린 투여 시스템
CN110869074B (zh) * 2017-05-12 2022-08-09 自主医疗保健公司 分层自适应闭环液体复苏和心血管药物给予系统
EP3438858A1 (en) * 2017-08-02 2019-02-06 Diabeloop Closed-loop blood glucose control systems and methods
JP2019107446A (ja) * 2017-12-15 2019-07-04 アークレイ株式会社 点滴注射の実施方法および点滴注射の実施装置
CN111542884B (zh) * 2017-12-21 2024-03-15 益首药物治疗股份公司 生理葡萄糖的闭环控制
US11278668B2 (en) 2017-12-22 2022-03-22 Glysens Incorporated Analyte sensor and medicant delivery data evaluation and error reduction apparatus and methods
US11255839B2 (en) 2018-01-04 2022-02-22 Glysens Incorporated Apparatus and methods for analyte sensor mismatch correction
USD928199S1 (en) 2018-04-02 2021-08-17 Bigfoot Biomedical, Inc. Medication delivery device with icons
US11147919B2 (en) 2018-04-23 2021-10-19 Medtronic Minimed, Inc. Methodology to recommend and implement adjustments to a fluid infusion device of a medication delivery system
US11158413B2 (en) * 2018-04-23 2021-10-26 Medtronic Minimed, Inc. Personalized closed loop medication delivery system that utilizes a digital twin of the patient
JP7124120B2 (ja) 2018-05-04 2022-08-23 インスレット コーポレイション 制御アルゴリズムベースの薬物送達システムのための安全制約
CA3112209C (en) 2018-09-28 2023-08-29 Insulet Corporation Activity mode for artificial pancreas system
WO2020077223A1 (en) 2018-10-11 2020-04-16 Insulet Corporation Event detection for drug delivery system
USD920343S1 (en) 2019-01-09 2021-05-25 Bigfoot Biomedical, Inc. Display screen or portion thereof with graphical user interface associated with insulin delivery
WO2021012075A1 (en) * 2019-07-19 2021-01-28 Medtrum Technologies Inc. Integrated drug infusion device
EP4007624A4 (en) * 2019-08-01 2023-04-05 Medtrum Technologies Inc. DRIVE DEVICE AND MEDICATION INFUSION DEVICE
KR102312548B1 (ko) * 2019-08-07 2021-10-18 주식회사 아이센스 생체 정보 측정 데이터의 노이즈 처리 방법
US11801344B2 (en) 2019-09-13 2023-10-31 Insulet Corporation Blood glucose rate of change modulation of meal and correction insulin bolus quantity
WO2021054142A1 (ja) * 2019-09-18 2021-03-25 Ｐｈｃホールディングス株式会社 薬剤投与判定システムおよび薬剤投与判定プログラム
US11241537B2 (en) * 2019-09-20 2022-02-08 Medtronic Minimed, Inc. Contextual personalized closed-loop adjustment methods and systems
US11213623B2 (en) * 2019-09-20 2022-01-04 Medtronic Minimed, Inc. Infusion systems and related personalized bolusing methods
US11935637B2 (en) 2019-09-27 2024-03-19 Insulet Corporation Onboarding and total daily insulin adaptivity
US11654236B2 (en) * 2019-11-22 2023-05-23 Tandem Diabetes Care, Inc. Systems and methods for automated insulin delivery for diabetes therapy
EP4354455A2 (en) 2019-12-06 2024-04-17 Insulet Corporation Techniques and devices providing adaptivity and personalization in diabetes treatment
US11833329B2 (en) 2019-12-20 2023-12-05 Insulet Corporation Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns
US11551802B2 (en) 2020-02-11 2023-01-10 Insulet Corporation Early meal detection and calorie intake detection
US11547800B2 (en) 2020-02-12 2023-01-10 Insulet Corporation User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system
EP4103046A4 (en) * 2020-02-14 2024-03-13 Dexcom Inc DECISION SUPPORT AND TREATMENT MANAGEMENT SYSTEMS
CN111150901B (zh) * 2020-02-26 2020-11-27 苏州喜全软件科技有限公司 一种基于电流脉冲渗透的胰岛素泵及注射方法
US11607493B2 (en) 2020-04-06 2023-03-21 Insulet Corporation Initial total daily insulin setting for user onboarding
US11684716B2 (en) 2020-07-31 2023-06-27 Insulet Corporation Techniques to reduce risk of occlusions in drug delivery systems
CN112397176A (zh) * 2020-10-16 2021-02-23 温州医科大学 基于宫缩信号和LightGBM的缩宫素剂量智能调控方法及系统
WO2022187315A1 (en) * 2021-03-02 2022-09-09 Insulet Corporation Adaptation of automatic insulin delivery (aid) for users with basal to bolus mismatch
US11904140B2 (en) 2021-03-10 2024-02-20 Insulet Corporation Adaptable asymmetric medicament cost component in a control system for medicament delivery
US11738144B2 (en) 2021-09-27 2023-08-29 Insulet Corporation Techniques enabling adaptation of parameters in aid systems by user input
CN113951879B (zh) * 2021-12-21 2022-04-05 苏州百孝医疗科技有限公司 血糖预测方法和装置、监测血糖水平的系统

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090112478A1 (en) * 2007-10-31 2009-04-30 Medtronic Minimed, Inc. Modified Sensor Calibration Algorithm
US20100057041A1 (en) * 2008-08-31 2010-03-04 Abbott Diabetes Care, Inc. Closed Loop Control With Reference Measurement And Methods Thereof

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4373527B1 (en) 1979-04-27 1995-06-27 Univ Johns Hopkins Implantable programmable medication infusion system
US4573994A (en) 1979-04-27 1986-03-04 The Johns Hopkins University Refillable medication infusion apparatus
US4685903A (en) 1984-01-06 1987-08-11 Pacesetter Infusion, Ltd. External infusion pump apparatus
US4562751A (en) 1984-01-06 1986-01-07 Nason Clyde K Solenoid drive apparatus for an external infusion pump
US4678408A (en) 1984-01-06 1987-07-07 Pacesetter Infusion, Ltd. Solenoid drive apparatus for an external infusion pump
US4755173A (en) 1986-02-25 1988-07-05 Pacesetter Infusion, Ltd. Soft cannula subcutaneous injection set
US5299571A (en) 1993-01-22 1994-04-05 Eli Lilly And Company Apparatus and method for implantation of sensors
US5791344A (en) 1993-11-19 1998-08-11 Alfred E. Mann Foundation For Scientific Research Patient monitoring system
US5497772A (en) 1993-11-19 1996-03-12 Alfred E. Mann Foundation For Scientific Research Glucose monitoring system
US5390671A (en) 1994-03-15 1995-02-21 Minimed Inc. Transcutaneous sensor insertion set
US5391250A (en) 1994-03-15 1995-02-21 Minimed Inc. Method of fabricating thin film sensors
US5569186A (en) 1994-04-25 1996-10-29 Minimed Inc. Closed loop infusion pump system with removable glucose sensor
US5482473A (en) 1994-05-09 1996-01-09 Minimed Inc. Flex circuit connector
US5586553A (en) 1995-02-16 1996-12-24 Minimed Inc. Transcutaneous sensor insertion set
DE69622421T2 (de) 1995-11-13 2003-03-20 Medtronic Minimed Inc Verfahren und zusammensetzungen zur verabreichung monomerer proteine
JP2000500656A (ja) 1995-11-22 2000-01-25 ミニメッド インコーポレイティド 化学的増幅及び光学センサーを用いる生物分子の検出
DE69717117T2 (de) 1996-08-05 2003-07-17 Prolinx Inc Komplexreagenzien und komplexe, die eine borsäureverbindung enthalten
US5954643A (en) 1997-06-09 1999-09-21 Minimid Inc. Insertion set for a transcutaneous sensor
US6579690B1 (en) 1997-12-05 2003-06-17 Therasense, Inc. Blood analyte monitoring through subcutaneous measurement
US6554798B1 (en) 1998-08-18 2003-04-29 Medtronic Minimed, Inc. External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
US5951521A (en) 1998-09-25 1999-09-14 Minimed Inc. Subcutaneous implantable sensor set having the capability to remove deliver fluids to an insertion site
EP1115435B2 (en) 1998-09-30 2012-07-25 Medtronic MiniMed, Inc. Communication station and software with an infusion pump, analyte monitor, analyte meter, or the like
AU6255699A (en) 1998-10-08 2000-04-26 Minimed, Inc. Telemetered characteristic monitor system
US7806886B2 (en) * 1999-06-03 2010-10-05 Medtronic Minimed, Inc. Apparatus and method for controlling insulin infusion with state variable feedback
US7890295B2 (en) * 2000-02-23 2011-02-15 Medtronic Minimed, Inc. Real time self-adjusting calibration algorithm
WO2005061041A1 (en) * 2002-10-11 2005-07-07 Becton, Dickinson And Company Insulin delivery system with sensor
CN100446724C (zh) * 2005-11-28 2008-12-31 中国科学院电子学研究所 用于闭环胰岛素注射的无创血糖仪
US20100121314A1 (en) * 2006-10-12 2010-05-13 Mario Iobbi Regulated drug delivery system
US20080228056A1 (en) 2007-03-13 2008-09-18 Michael Blomquist Basal rate testing using frequent blood glucose input
WO2008135329A1 (en) * 2007-05-03 2008-11-13 Novo Nordisk A/S Safety system for insulin delivery advisory algoritms
US8483830B2 (en) * 2008-04-04 2013-07-09 Enteromedics Inc. Methods and systems for glucose regulation
US20100057040A1 (en) * 2008-08-31 2010-03-04 Abbott Diabetes Care, Inc. Robust Closed Loop Control And Methods
CA3037726C (en) * 2008-09-15 2021-11-16 Deka Products Limited Partnership Systems and methods for fluid delivery
AU2010210157B2 (en) * 2009-02-04 2014-08-28 Sanofi-Aventis Deutschland Gmbh Medical system and method for providing information for glycemic control
CN102334113B (zh) * 2009-02-25 2016-01-13 弗吉尼亚大学专利基金会 通过低血糖风险评估和平滑降低胰岛素递送的基于cgm的低血糖预防
EP4231307A1 (en) * 2009-05-29 2023-08-23 University Of Virginia Patent Foundation System coordinator and modular architecture for open-loop and closed-loop control of diabetes
EP2521483B1 (en) * 2010-02-11 2016-08-17 The Regents of The University of California System to deliver insulin to a subject
US8579879B2 (en) * 2010-02-19 2013-11-12 Medtronic Minimed, Inc. Closed-loop glucose control startup
US10561785B2 (en) * 2010-06-22 2020-02-18 Medtronic Minimed, Inc. Method and/or system for closed-loop control of glucose to a treatment range
JP6047097B2 (ja) * 2010-10-31 2016-12-21 トラスティーズ オブ ボストン ユニバーシティ 血糖制御システム

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090112478A1 (en) * 2007-10-31 2009-04-30 Medtronic Minimed, Inc. Modified Sensor Calibration Algorithm
US20100057041A1 (en) * 2008-08-31 2010-03-04 Abbott Diabetes Care, Inc. Closed Loop Control With Reference Measurement And Methods Thereof

Also Published As

Publication number Publication date
KR102147850B1 (ko) 2020-08-26
JP2015528348A (ja) 2015-09-28
EP2897071B1 (en) 2019-05-22
KR102147838B1 (ko) 2020-08-26
CA2885003A1 (en) 2014-03-06
WO2014035672A3 (en) 2014-09-12
KR102054540B1 (ko) 2019-12-10
CN105046042A (zh) 2015-11-11
CN105169525B (zh) 2019-04-02
CA2884997A1 (en) 2014-03-06
JP6039016B2 (ja) 2016-12-07
JP2015192889A (ja) 2015-11-05
CN105046042B (zh) 2018-10-09
WO2014035672A2 (en) 2014-03-06
CN105169525A (zh) 2015-12-23
JP2015165970A (ja) 2015-09-24
AU2013309344B2 (en) 2018-11-08
KR20150045522A (ko) 2015-04-28
CA2882300A1 (en) 2014-03-06
AU2013309344A1 (en) 2015-02-26
KR20150050563A (ko) 2015-05-08
CN104769595A (zh) 2015-07-08
CN104769595B (zh) 2017-12-08
JP6073478B2 (ja) 2017-02-01
CA2885003C (en) 2021-06-22
EP2897070A1 (en) 2015-07-22
EP2897071A1 (en) 2015-07-22
CA2882300C (en) 2020-12-29
KR20150043534A (ko) 2015-04-22
CA2884997C (en) 2020-05-26

Similar Documents

Publication Publication Date Title
US20200353168A1 (en) Safeguarding measures for a closed-loop insulin infusion system
US11628250B2 (en) Temporary target glucose values for temporary reductions in fluid delivery
US9999728B2 (en) Regulating entry into a closed-loop operating mode of an insulin infusion system
US10496797B2 (en) Blood glucose validation for a closed-loop operating mode of an insulin infusion system
US9849239B2 (en) Generation and application of an insulin limit for a closed-loop operating mode of an insulin infusion system
US9878096B2 (en) Generation of target glucose values for a closed-loop operating mode of an insulin infusion system
US9623179B2 (en) Safeguarding techniques for a closed-loop insulin infusion system
CA2885003C (en) Safeguarding techniques for a closed-loop insulin infusion system
AU2015200834A1 (en) Safeguarding techniques for a closed-loop insulin infusion system
AU2015200829B2 (en) Safeguarding techniques for a closed-loop insulin infusion system
CA2884999C (en) Safeguarding measures for a closed-loop insulin infusion system

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20150212

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

17Q First examination report despatched

Effective date: 20181016

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20210118